742 results on '"A. Sepe"'
Search Results
2. A Journey Into the World of Thermosets
- Author
-
Sepe, Mike
- Subjects
Crosslinked polymers ,Thermoplastics ,Business ,Chemicals, plastics and rubber industries - Abstract
Most thermoset molding processes still treat the mold like a black box where the curing process is invisible and mysterious, and nobody knows what is happening to the material until [...]
- Published
- 2024
3. PART 2: Moisture Analysis Revisited: Once you've selected the right moisture analyzer, the task of method development begins. Don't skip this step or you'll run into problems. Here's what happened in my lab decades ago
- Author
-
Sepe, Mike
- Subjects
Moisture -- Methods ,Analytical instruments -- Methods ,Business ,Chemicals, plastics and rubber industries - Abstract
Let us assume that you have selected an appropriate moisture analyzer, one that is capable of distinguishing between moisture and all the other volatile compounds that can be evolved from [...]
- Published
- 2024
4. What's the Allowable Moisture Content in Nylons? It Depends: Part 2
- Author
-
Sepe, Michael
- Subjects
Raw materials ,Nylon ,Business ,Chemicals, plastics and rubber industries - Abstract
Operating within guidelines from material suppliers can produce levels of polymer degradation. Get around it with better control over either the temperature of the melt or the barrel residence time. [...]
- Published
- 2023
5. What is the Allowable Moisture Content in Nylons? It Depends (Part 1)
- Author
-
Sepe, Michael
- Subjects
Nylon ,Hydrolysis ,Business ,Chemicals, plastics and rubber industries - Abstract
A lot of the nylon that is processed is filled or reinforced, but the data sheets generally don't account for this, making drying recommendations confusing. Here's what you need to [...]
- Published
- 2023
6. Moisture Analysis Revisited
- Author
-
Sepe, Mike
- Subjects
Moisture ,Polymers ,Business ,Chemicals, plastics and rubber industries - Abstract
The first task in moisture measurement is to purchase an instrument that is based on sound fundamentals. Then, before it goes into use, method development must be undertaken for all [...]
- Published
- 2024
7. PART 2: The Fantasy and Reality of Raw Material Shelf Life
- Author
-
Sepe, Mike
- Subjects
Raw materials ,Thermoplastics ,Business ,Chemicals, plastics and rubber industries - Abstract
For the vast majority of thermoplastics, the stability of the materials can be stated in years, not months. But there are exceptions where shelf life can be a serious issue. [...]
- Published
- 2024
8. Tracing the History of Polymeric Materials, Part 26: High-Performance Thermoplastics
- Author
-
Sepe, Michael
- Subjects
Thermoplastics ,Business ,Chemicals, plastics and rubber industries - Abstract
The majority of the polymers that today we rely on for outstanding performance--such as polysulfone, polyethersulfone, polyphenylsulfone and PPS--were introduced in the period between 1965 and 1985. Here's how they [...]
- Published
- 2023
9. Tracing the History of Polymeric Materials--Silicone: The long road to the development of silicone resulted in a chemistry that is remarkably versatile
- Author
-
Sepe, Mike
- Subjects
Dow Corning Corp. -- Joint ventures -- Research agreements ,General Electric Co. -- Research agreements -- Joint ventures ,Pesticides industry -- Research agreements -- Joint ventures ,Silicones ,Herbicides -- Research agreements -- Joint ventures ,Plastics industry -- Research agreements -- Joint ventures ,Chemical tests and reagents ,Chemical industry -- Research agreements -- Joint ventures ,Electrical equipment and supplies industry -- Research agreements -- Joint ventures ,Company joint venture ,Business ,Chemicals, plastics and rubber industries - Abstract
After the 1938 meeting between General Electric and Corning Glass Works discussed in last month's column, two parallel paths developed that led to the creation of commercial silicones. At Corning, [...]
- Published
- 2023
10. PART 1: The Fantasy and Reality of Raw Material Shelf Life
- Author
-
Sepe, Mike
- Subjects
Raw materials ,Nylon ,Packaging ,Business ,Chemicals, plastics and rubber industries - Abstract
Is a two-year-old hygroscopic resin kept in its original packaging still useful? Let's try to answer that question and clear up some misconceptions. A few weeks ago, a longtime colleague [...]
- Published
- 2023
11. Tracing the History of Polymeric Materials, Part 27: LCP: Liquid-crystal polymers debuted in the mid-1980s, but the history of the chemistry associated with this class of materials actually starts a century earlier
- Author
-
Sepe, Michael
- Subjects
Polymer industry ,Polymer liquid crystals ,Business ,Chemicals, plastics and rubber industries - Abstract
More than 40 years ago, I was asked by a client to locate a material with the greatest available heat resistance. This was before the era of the online databases [...]
- Published
- 2023
12. Imagine A World Where Polymers Were First
- Author
-
Sepe, Mike
- Subjects
Polymer industry ,Polymers ,Business ,Chemicals, plastics and rubber industries - Abstract
One reason for the disproportionate attention that plastics receive in the environmental conversation is that they are newcomers. Perhaps, if we had been relying on them for thousands of years, [...]
- Published
- 2023
13. Tracing the History of Polymeric Materials: Part 24: Here we focus on silicones, more properly known as siloxanes. This is a class of materials where no carbon is present in the polymer backbone
- Author
-
Sepe, Michael
- Subjects
Silicones ,Polymer industry ,Elastomers ,Business ,Chemicals, plastics and rubber industries - Abstract
Almost all polymers are based on carbon. The backbone chemistry of our most common polymers--polyethylene, polypropylene, PVC, and polystyrene--is exclusively carbon with different pendant groups defining the properties of each [...]
- Published
- 2022
14. PART 28 Tracing the History of Polymeric Materials: Polyurethane: This material family has unparalleled versatility, not only in terms of the forms the material can take, but in the different ways in which it can be processed
- Author
-
Sepe, Mike
- Subjects
Bayer Corp. ,Isocyanates ,Pesticides industry ,Nylon ,Herbicides ,Polyurethanes ,Chemical industry ,Polyols ,Business ,Chemicals, plastics and rubber industries - Abstract
In the same era when Wallace Carothers was conducting his experiments to synthesize polyesters and nylon at DuPont, a German chemist, Otto Bayer, was investigating another type of reaction using [...]
- Published
- 2023
15. PART 13: Tracing the History of Polymeric Materials: The histories of nylons and polyesters are intertwined, and it takes some knowledge of chemistry to understand why
- Author
-
Sepe, Mike
- Subjects
Nylon ,Polyols ,Business ,Chemicals, plastics and rubber industries - Abstract
The same wave of innovation that produced the development of nylon also created synthetic polyesters. Julian Hill, a member of the team at DuPont led by Wallace Carothers, first synthesized [...]
- Published
- 2021
16. Tracing the History of Polymeric Materials: Part 23: PPO was a promising new high-performance thermoplastic, but it could be made useful only by mixing it with a humble commodity resin
- Author
-
Sepe, Mike
- Subjects
GE Plastics ,Polyetherimide ,Business ,Chemicals, plastics and rubber industries - Abstract
As discussed in my last column, the engineering thermoplastic polyphenylene oxide (PPO) was a commercial reality by 1960. On paper, the polymer was a magnificent accomplishment, with thermal and mechanical [...]
- Published
- 2022
17. Tracing the History of Polymeric Materials: Part 22: Behind the scenes of the discovery of PPO
- Author
-
Sepe, Michael
- Subjects
Polymers ,Business ,Chemicals, plastics and rubber industries - Abstract
By the mid-1950s, polymer chemists had come to understand that there was a relationship between the stiffness of the molecular chains that make up the polymer backbone and the property [...]
- Published
- 2022
18. PART 12: Tracing the History of Polymeric Materials: The industry has learned a lot about the advantages and disadvantages of polycarbonate during its more than 60-year history, and it would be difficult to imagine a world in which it did not exist
- Author
-
Sepe, Mike
- Subjects
Microcomputers -- Case studies ,Polycarbonates -- Case studies ,Business ,Chemicals, plastics and rubber industries - Abstract
When polycarbonate was first created it appeared to be a material that was all upside. Transparent, impact resistant, and able to withstand the short-term effects of exposure to boiling-water temperatures, [...]
- Published
- 2021
19. Tracing the History of Polymeric Materials: How polycarbonate came about, virtually simultaneously, through the efforts of two industry giants
- Author
-
Sepe, Mike
- Subjects
General Electric Co. ,Acrylonitrile ,Butadiene ,Electrical equipment and supplies industry ,Polycarbonates ,Business ,Chemicals, plastics and rubber industries - Abstract
Throughout the 1930s the development and commercialization of new polymers occurred at a rapid pace. PVC, polystyrene, polyethylene, acrylic, and moldable cellulosics all came of age in this decade. By [...]
- Published
- 2021
20. Tracing the History of Polymeric Materials: Part 19: Aliphatic polyketone is a material that gets little attention but is similar in chemistry to nylons, polyesters and acetals
- Author
-
Sepe, Michael
- Subjects
Polyphenylene sulphide ,Polyethylene ,Polyols ,Crystalline polymers ,Business ,Chemicals, plastics and rubber industries - Abstract
Nylons, polyesters and acetals form a family of semi-crystalline polymers that represent the midrange rungs on the price/performance ladder. They fit between the semi-crystalline commodity materials like polyethylene and polypropylene [...]
- Published
- 2022
21. Tracing the History of Polymeric Materials: The accidental discovery of Teflon
- Author
-
Sepe, Mike
- Subjects
Uranium -- Research ,Business ,Chemicals, plastics and rubber industries - Abstract
Some time ago, I was watching an online presentation by a physicist who was discussing the process of synthesizing heavy elements. These are the elements on the periodic table that [...]
- Published
- 2021
22. Tracing the History of Polymeric Materials: The story of nylon, the first true engineering thermoplastic
- Author
-
Sepe, Mike
- Subjects
Nylon ,Thermoplastics ,Company business management ,Business ,Chemicals, plastics and rubber industries - Abstract
DuPont became involved in the cellulosics business when it acquired the rights to cellophane from a French company founded by Jacques Brandenberger. As innovative as cellophane was, it was a [...]
- Published
- 2021
23. Tracing the History of Polymeric Materials: How--and when-cellulose-based chemistry led to the discovery of cellophane
- Author
-
Sepe, Mike
- Subjects
Celanese Corp. -- Discovery and exploration ,Gums and resins industry -- Discovery and exploration ,Cellulose -- Discovery and exploration ,Business ,Chemicals, plastics and rubber industries - Abstract
Cellulose-based chemistry was one of the principal foundations for the birth of the polymer industry. But as we have discussed previously, the initial compounds based on cellulose nitrate were highly [...]
- Published
- 2021
24. PART 5: Tracing the History of Polymeric Materials
- Author
-
Sepe, Mike
- Subjects
Business ,Chemicals, plastics and rubber industries - Abstract
Creation of an invention like phenolic can be traced through a long chain of events and contributors. Here's the full story. A review of the history of technological developments shows [...]
- Published
- 2021
25. Tracing the History of Polymeric Materials: Part 18: The road from discovery in the lab to commercial viability can be long, and this was certainly the case for acetal polymers
- Author
-
Sepe, Michael
- Subjects
Polymer industry ,Acetal resins ,Formaldehyde ,Business ,Chemicals, plastics and rubber industries - Abstract
The commercial introduction of the class of materials known as acetals (or polyoxymethylene, POM) occurred in i960 when DuPont started producing the material known as Delrin. However, as we have [...]
- Published
- 2022
26. Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry
- Author
-
Limongelli G, Iucolano S, Monda E, Elefante P, De Stasio C, Lubrano I, Caiazza M, Mazzella M, Fimiani F, Galdo M, De Marchi G, Esposito M, Rubino M, Cirillo A, Fusco A, Esposito A, Trama U, Esposito S, Scarano G, Sepe J, Andria G, Orlando V, Menditto E, Chiodini P, Campania Rare Disease, Iolascon A, Franzese A, Sanduzzi Zamparelli A, Tessitore A, Romano A, Venosa A, Nunzia Olivieri A, Bianco A, La Manna A, Cerbone AM, Spasiano A, Agnese Stanziola A, Colao A, De Bellis A, Gambale A, Toriello A, Tufano A, Ciampa A, Maria Risitano A, Pisani A, Russo A, Volpe A, De Martino B, Amato B, De Fusco C, Piscopo C, Selleri C, Tucci C, Pignata C, Cioffi D, Melis D, Pasquali D, De Brasi D, Spitaleri D, Russo D, Martellotta D, De Michele E, Varricchio E, Miraglia Del Giudice E, Coscioni E, Cimino E, Pane F, Tranfa F, Pollio F, Lonardo F, Nuzzi F, Simonelli F, Trojsi F, Habetswallner F, Valentini G, Cerbone G, Parenti G, Tedeschi G, Capasso G, Battista Rossi G, Gaglione G, Sarnelli G, Argenziano G, Bellastella G, De Michele G, Fiorentino G, Spadaro G, Scala I, Santoro L, Zeppa L, Auricchio L, Elio Adinolfi L, Alessio M, Amitrano M, Savanelli MC, Russo MG, Ferrucci MG, Carbone MT, Pellecchia MT, Salerno M, Melone M, Del Donno M, Vitale M, Triggiani M, Della Monica M, Lo Presti M, Tenuta M, Mignogna MD, Schiavulli M, Zacchia M, Brunetti-Pierri N, Iovino P, Moscato P, Iandoli R, Scarpa R, Russo R, Troisi S, Sbordone S, Perrotta S, Fecarotta S, Sampaolo S, Cicalese V., Limongelli, Giuseppe, Iucolano, Stefano, Monda, Emanuele, Elefante, Pasquale, De Stasio, Chiara, Lubrano, Imma, Caiazza, Martina, Mazzella, Marialuisa, Fimiani, Fabio, Galdo, Maria, De Marchi, Giulia, Esposito, Martina, Rubino, Marta, Cirillo, Annapaola, Fusco, Adelaide, Esposito, Augusto, Trama, Ugo, Esposito, Salvatore, Scarano, Gioacchino, Sepe, Joseph, Andria, Generoso, Orlando, Valentina, Menditto, Enrica, Chiodini, Paolo, Iolascon, Achille, Franzese, Adriana, Sanduzzi Zamparelli, Alessandro, Tessitore, Alessandro, Romano, Alfonso, Venosa, Alfredo, Nunzia Olivieri, Alma, Bianco, Andrea, La Manna, Angela, Cerbone, Anna Maria, Spasiano, Anna, Agnese Stanziola, Anna, Colao, Annamaria, De Bellis, Annamaria, Gambale, Antonella, Toriello, Antonella, Tufano, Antonella, Ciampa, Antonio, Maria Risitano, Antonio, Pisani, Antonio, Russo, Antonio, Volpe, Antonio, De Martino, Bernardo, Amato, Bruno, De Fusco, Carmela, Piscopo, Carmelo, Selleri, Carmine, Tucci, Celeste, Pignata, Claudio, Cioffi, Daniela, Melis, Daniela, Pasquali, Daniela, De Brasi, Daniele, Spitaleri, Daniele, De Brasi, Davide, Russo, Domenico, Martellotta, Donata, De Michele, Elisa, Varricchio, Elziario, Miraglia Del Giudice, Emanuele, Coscioni, Enrico, Cimino, Ernesto, Pane, Fabrizio, Tranfa, Fausto, Pollio, Filiberto, Lonardo, Fortunato, Nuzzi, Francesca, Simonelli, Francesca, Trojsi, Francesca, Habetswallner, Francesco, Valentini, Gabriele, Cerbone, Gaetana, Parenti, Giancarlo, Tedeschi, Gioacchino, Capasso, Giovambattista, Battista Rossi, Giovanni, Gaglione, Giovanni, Sarnelli, Giovanni, Argenziano, Giuseppe, Bellastella, Giuseppe, De Michele, Giuseppe, Fiorentino, Giuseppe, Spadaro, Giuseppe, Scala, Iri, Santoro, Lucio, Zeppa, Lucio, Auricchio, Luigi, Elio Adinolfi, Luigi, Alessio, Maria, Amitrano, Maria, Savanelli, Maria Cristina, Russo, Maria Giovanna, Ferrucci, Maria Grazia, Carbone, Maria Teresa, Pellecchia, Maria Teresa, Salerno, Mariacarolina, Melone, Marina, Del Donno, Mario, Vitale, Mario, Triggiani, Massimo, Della Monica, Matteo, Lo Presti, Maurizio, Tenuta, Maurizio, Mignogna, Michele Davide, Schiavulli, Michele, Zacchia, Miriam, Brunetti-Pierri, Nicola, Iovino, Paola, Moscato, Paolo, Iandoli, Raffaele, Scarpa, Raffaele, Russo, Romualdo, Troisi, Salvatore, Sbordone, Sandro, Perrotta, Silverio, Fecarotta, Simona, Sampaolo, Simone, Cicalese, Virgilio, Limongelli, G, Iucolano, S, Monda, E, Elefante, P, De Stasio, C, Lubrano, I, Caiazza, M, Mazzella, M, Fimiani, F, Galdo, M, De Marchi, G, Esposito, M, Rubino, M, Cirillo, A, Fusco, A, Esposito, A, Trama, U, Esposito, S, Scarano, G, Sepe, J, Andria, G, Orlando, V, Menditto, E, Chiodini, P, Campania Rare, Disease, Iolascon, A, Franzese, A, Sanduzzi Zamparelli, A, Tessitore, A, Romano, A, Venosa, A, Nunzia Olivieri, A, Bianco, A, La Manna, A, Cerbone, Am, Spasiano, A, Agnese Stanziola, A, Colao, A, De Bellis, A, Gambale, A, Toriello, A, Tufano, A, Ciampa, A, Maria Risitano, A, Pisani, A, Russo, A, Volpe, A, De Martino, B, Amato, B, De Fusco, C, Piscopo, C, Selleri, C, Tucci, C, Pignata, C, Cioffi, D, Melis, D, Pasquali, D, De Brasi, D, Spitaleri, D, Russo, D, Martellotta, D, De Michele, E, Varricchio, E, Miraglia Del Giudice, E, Coscioni, E, Cimino, E, Pane, F, Tranfa, F, Pollio, F, Lonardo, F, Nuzzi, F, Simonelli, F, Trojsi, F, Habetswallner, F, Valentini, G, Cerbone, G, Parenti, G, Tedeschi, G, Capasso, G, Battista Rossi, G, Gaglione, G, Sarnelli, G, Argenziano, G, Bellastella, G, De Michele, G, Fiorentino, G, Spadaro, G, Scala, I, Santoro, L, Zeppa, L, Auricchio, L, Elio Adinolfi, L, Alessio, M, Amitrano, M, Savanelli, Mc, Russo, Mg, Ferrucci, Mg, Carbone, Mt, Pellecchia, Mt, Salerno, M, Melone, M, Del Donno, M, Vitale, M, Triggiani, M, Della Monica, M, Lo Presti, M, Tenuta, M, Mignogna, Md, Schiavulli, M, Zacchia, M, Brunetti-Pierri, N, Iovino, P, Moscato, P, Iandoli, R, Scarpa, R, Russo, R, Troisi, S, Sbordone, S, Perrotta, S, Fecarotta, S, Sampaolo, S, and Cicalese, V.
- Subjects
Pediatrics ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Home therapy ,rare diseases ,030204 cardiovascular system & hematology ,Campania region ,Covid-19 ,Italy ,patient registry ,Disease Outbreaks ,03 medical and health sciences ,COVID-19 Testing ,0302 clinical medicine ,Pandemic ,Health care ,medicine ,Retrospective analysis ,Humans ,AcademicSubjects/MED00860 ,Registries ,030212 general & internal medicine ,Medical diagnosis ,Pandemics ,Retrospective Studies ,business.industry ,Public Health, Environmental and Occupational Health ,Outbreak ,General Medicine ,Original Article ,business ,Delivery of Health Care ,Rare disease - Abstract
Background The aims of this study were: to investigate the capacity of the rare disease healthcare network in Campania to diagnose patients with rare diseases during the outbreak of Covid-19; and to shed light on problematic diagnoses during this period. Methods To describe the impact of the Covid-19 pandemic on the diagnosis of patients with rare diseases, a retrospective analysis of the Campania Region Rare Disease Registry was performed. A tailored questionnaire was sent to rare disease experts to investigate major issues during the emergency period. Results Prevalence of new diagnoses of rare disease in March and April 2020 was significantly lower than in 2019 (117 versus 317, P Conclusions This study describes the effects of the Covid-19 outbreak on the diagnosis of rare disease in a single Italian region and investigates potential issues of diagnosis and management during this period.
- Published
- 2021
27. In this installment we discuss the discovery of Bakelite, the first truly synthetic polymer, known today as phenolic: Tracing the History of Polymeric Materials
- Author
-
Sepe, Mike
- Subjects
Polymers ,Business ,Chemicals, plastics and rubber industries - Abstract
In 1863, the year after the nitrocellulose-based plastic Parkesine was awarded the bronze medal at the Great International Exhibition in London, Leo Baekeland was born in Belgium. The son of [...]
- Published
- 2021
28. The relevance of relational capabilities in collaborative decisions
- Author
-
Massimo Aria, Fabiana Sepe, Jay Brian Barney, Cihan Cobanoglu, V. Della Corte, Giovanna Del Gaudio, DELLA CORTE, Valentina, Aria, Massimo, DEL GAUDIO, Giovanna, Brian Barney, Jay, Cobanoglu, Cihan, and Sepe, Fabiana
- Subjects
Variable (computer science) ,Focus (computing) ,Knowledge management ,business.industry ,Computer science ,Tourism, Leisure and Hospitality Management ,Perspective (graphical) ,Tourist destinations ,Relevance (information retrieval) ,business ,Hospitality industry ,Relational view - Abstract
PurposeThis study aims to focus on inter-firm collaboration, exploring the main capabilities that can make a business more or less open to collaboration; it also considers the role of both firm-specific and relationship-specific capabilities. The paper proposes a model that can be used to study how the combination of the two categories of capabilities determines a firm’s approach to collaboration.Design/methodology/approachThrough a survey of high-end hotels in tourist destinations in Italy and the USA, this paper tests variable connected with firm-specific and relationship-specific aspects, using confirmatory factor analysis.FindingsFirms with greater capabilities are less open to cooperation; weaker firms with fewer resources appear to be more inclined to cooperate, probably to gain access to resources and competencies they do not possess.Research limitations/implicationsFrom a scientific perspective, this paper suggests an analysis based on both individual and relational capabilities when deciding whether to collaborate, while most studies based on a relational view just consider relational capabilities. The study could be enlarged to other countries and contexts.Practical implicationsFrom a practical perspective, it indicates the importance of accounting for different and sometimes diverging aspects when deciding to cooperate.Social implicationsIn terms of social implications, it shows that, apart from the relational capabilities they have, potential partners can decide not to collaborate.Originality/valueThe paper suggests a method of analyzing both individual and relational capabilities when deciding whether to engage in a collaboration. It shows that firms’ behavior does not necessarily depend on the firm’s relational capabilities.
- Published
- 2021
29. A Brief History Lesson on Materials: In this series we'll delve into a discerning look back into the history of our industry and how we all got here
- Author
-
Sepe, Mike
- Subjects
Business ,Chemicals, plastics and rubber industries - Abstract
Periodically I get e-mails asking me if I have heard of particular historical events related to the plastics industry. One of the stories that gets a lot of attention is [...]
- Published
- 2020
30. PART 6 of 7: Annealing Tips for Thermoplastic Polyurethanes: TPUs form physical, rather than chemical, crosslinks that can be broken by reheating. Formation of these crosslinks can be sped up by annealing, which improves a variety of properties
- Author
-
Sepe, Mike
- Subjects
Polyurethanes ,Isocyanates ,Annealing ,Business ,Chemicals, plastics and rubber industries - Abstract
Polyurethanes exhibit an incredible range of chemistries and structures that may be unmatched in the world of polymers. While all polyurethanes are fundamentally the product of a reaction between an [...]
- Published
- 2020
31. An investigation on parenting stress of children with cystic fibrosis
- Author
-
Silvia Toscano, Nicola Serra, Angela Sepe, Grazia Isabella Continisio, Maria Rosaria Esposito, Valeria Raia, Teresa Rea, Gianpaolo Gargiulo, Assunta Guillari, Maria Teresa Civitella, Silvio Simeone, Continisio, G. I., Serra, N., Guillari, A., Civitella, M. T., Sepe, A., Simeone, S., Gargiulo, G., Toscano, S., Esposito, M. R., Raia, V., Rea, T., Grazia Isabella, Continisio, Nicola, Serra, Assunta, Guillari, Maria Teresa, Civitella, Angela, Sepe, Simeone, S, Gianpaolo, Gargiulo, Silvia, Toscano, Maria Rosaria, Esposito, and Valeria Raia andTeresa, Rea
- Subjects
Biopsychosocial model ,Adult ,Male ,Parents ,Multivariate analysis ,Adolescent ,Psychological intervention ,Disease ,Cystic fibrosis ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Sex Factors ,030225 pediatrics ,0502 economics and business ,Medicine ,Humans ,Sibling ,Child ,Univariate analysis ,Parenting ,business.industry ,Clinical management ,Research ,05 social sciences ,lcsh:RJ1-570 ,Infant ,lcsh:Pediatrics ,Middle Aged ,medicine.disease ,Birth order ,Italy ,Socioeconomic Factors ,Child, Preschool ,Cystic fibrosi ,Female ,Parenting stress index ,business ,050203 business & management ,Stress, Psychological ,Clinical psychology - Abstract
Background: The management of chronic diseases, particularly in children, requires an integrated physical and psychological approach to both sick children and their family. This is the case of Cystic Fibrosis (CF), a complex genetic chronic disease, where, a comprehensive evaluation of the emotional impact and an effective multidimensional approach are indicated. Aim: This study investigates on parenting stress in children and adolescents with CF and its determinants related to parents, children and the disease severity. Methods: The study involved 34.04% adult males and 65.96% adult females (range 21-55 years) and 47 children with CF, 54.35% males and 45.65% females (range 1-17 years). The data were obtained through a Parenting Stress Index - Short Form (PSI-SF) questionnaire. According to the PSI-SF scoring system, three types of stress were detected: a typical stress pattern (normal), a high stress pattern (increased) and a defensive response, which may be considered as a high stress feature in children which requires monitoring and clinical evaluation. Results: This study shows a significant presence of stress in females (60.23%), of subject married (84.62%), unemployed (69.23%) and with education level such as "middle School" (61.54%). Concerning children of parents with high stress, it resulted most frequent children with one sibling (53.85%). Finally, by univariate analysis, it resulted a significant positive correlation between parenting stress and disease degree of children. Instead by multivariate analysis, we found that the variables: Number of siblings and Birth order were a significant positive and negative predictor of parenting stress respectively. Conclusion: An increased stress level was detected in less than one third of parents of subjects with CF. These data may be related to the psychological support which is part of the routine management of CF care team. However, as children's features seem to act as a determinant of stress more than parental ones, the parental-child dysfunction should be the target for further integrated interventions. Background: The management of chronic diseases, particularly in children, requires an integrated physical and psychological approach to both sick children and their family. This is the case of Cystic Fibrosis (CF), a complex genetic chronic disease, where, a comprehensive evaluation of the emotional impact and an effective multidimensional approach are indicated. Aim: This study investigates on parenting stress in children and adolescents with CF and its determinants related to parents, children and the disease severity. Methods: The study involved 34.04% adult males and 65.96% adult females (range 21-55 years) and 47 children with CF, 54.35% males and 45.65% females (range 1-17 years). The data were obtained through a Parenting Stress Index – Short Form (PSI-SF) questionnaire. According to the PSI-SF scoring system, three types of stress were detected: a typical stress pattern (normal), a high stress pattern (increased) and a defensive response, which may be considered as a high stress feature in children which requires monitoring and clinical evaluation. Results: This study shows a significant presence of stress in females (60.23%), of subject married (84.62%), unemployed (69.23%) and with education level such as “middle School” (61.54%). Concerning children of parents with high stress, it resulted most frequent children with one sibling (53.85%). Finally, by univariate analysis, it resulted a significant positive correlation between parenting stress and disease degree of children. Instead by multivariate analysis, we found that the variables: Number of siblings and Birth order were a significant positive and negative predictor of parenting stress respectively. Conclusion: An increased stress level was detected in less than one third of parents of subjects with CF. These data may be related to the psychological support which is part of the routine management of CF care team. However, as children’s features seem to act as a determinant of stress more than parental ones, the parental-child dysfunction should be the target for further integrated interventions.
- Published
- 2020
32. Tracing the History of Polymeric Materials: How acrylic was born: PART 20
- Author
-
Sepe, Mike
- Subjects
Acrylic acid ,Nylon ,Business ,Chemicals, plastics and rubber industries - Abstract
During the era when many of the polymers we have discussed previously (nylon, PET, PBT, PC, acetal) were undergoing development, another member of the family that has become a mainstay [...]
- Published
- 2022
33. Calcium daily intake and the efficacy of a training intervention on optimizing calcium supplementation therapy: A clinical audit
- Author
-
Raffaele Giannettino, Massimo Maddaloni, Carolina Sepe, Antonietta Scognamiglio, Giovanni Mansueto, Federica Coretti, Giovanni Paudice, Riccardo Muscariello, Salvatore Falanga, Elisabetta Palermo, Vincenzo D’Anna, Giovanni Napoli, Vincenzo Ruocco, Simone De Vita, Salvatore Scognamiglio, Ornella Romano, Giuseppe Bruno, Serena Ippolito, Michele Adolfo, Vincenzo Nuzzo, Domenico Rendina, Enrico Benedetto, Patrizia Parente, Maria Rosaria Martino, Paolo Peluso, Muscariello, Riccardo, Rendina, Domenico, Giannettino, Raffaele, Ippolito, Serena, Romano, Ornella, Coretti, Federica, De Vita, Simone, Martino, Maria Rosaria, Sepe, Carolina, Nuzzo, Vincenzo, Adolfo, Michele, Benedetto, Enrico, Bruno, Giuseppe, D’Anna, Vincenzo, Falanga, Salvatore, Maddaloni, Massimo, Mansueto, Giovanni, Napoli, Giovanni, Palermo, Elisabetta, Parente, Patrizia, Paudice, Giovanni, Peluso, Paolo, Ruocco, Vincenzo, Scognamiglio, Antonietta, and Scognamiglio, Salvatore
- Subjects
Adult ,Male ,Clinical audit ,Health Knowledge, Attitudes, Practice ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Training intervention ,education ,Population ,Medicine (miscellaneous) ,chemistry.chemical_element ,030209 endocrinology & metabolism ,030204 cardiovascular system & hematology ,Calcium ,Recommended Dietary Allowances ,Drug Prescriptions ,03 medical and health sciences ,0302 clinical medicine ,Calcium supplementation ,General Practitioners ,Intervention (counseling) ,Internal medicine ,Vitamin D and neurology ,Humans ,Medicine ,Practice Patterns, Physicians' ,Medical prescription ,Aged ,Medical Audit ,education.field_of_study ,Nutrition and Dietetics ,business.industry ,Feeding Behavior ,Middle Aged ,Drug Utilization ,Calcium, Dietary ,Italy ,chemistry ,Dietary Supplements ,Education, Medical, Continuing ,Female ,Diet, Healthy ,Cardiology and Cardiovascular Medicine ,business - Abstract
Calcium is an essential element for human health, with key roles in the prevention and therapy of multifactorial conditions. Calcium dietary intake is often insufficient in the general population. The aim of this study was to perform a clinical audit for general practitioners (GPs) to understand the efficacy of training intervention on doctors' awareness about dietary calcium and supplements.General practice outpatients were enrolled (Before Clinical Audit, BCA) from the same sanitary district, and calcium dietary intake was evaluated with a validated questionnaire, also collecting information about the consumption of calcium and vitamin D supplements. Then, a training intervention with a frontal lesson and discussion with GPs involved was performed. After one month of this intervention, a second outpatient enrolment was performed (Post Clinical Audit, PCA) in the same general practices to evaluate differences in nutritional suggestions and supplement prescription by GPs. In BCA, the calcium dietary intake was low, with nobody reaching 1000 mg as suggested by the guidelines. Only 6.6% and 24.5% took calcium and vitamin D supplements, respectively; in the PCA, these percentages increased to 28% and 78% for calcium and vitamin D supplements, respectively (p 0.01 PCA vs BCA). There were no differences in calcium dietary intake between BCA and PCA.Training intervention on GPs was successful to sensitize them regarding calcium intake problems; GPs tended to increase the prescription of supplements but not to suggest changes in dietary habits.
- Published
- 2021
34. The innate immune system in human kidney inflammaging
- Author
-
Carmelo Libetta, Marilena Gregorini, Vincenzo Sepe, and Teresa Rampino
- Subjects
Nephrology ,Aging ,medicine.medical_specialty ,Review ,Kidney ,Mice ,Immune system ,Internal medicine ,medicine ,Animals ,Humans ,Aged ,Innate immune system ,business.industry ,Acute kidney injury ,Pattern recognition receptor ,Endothelial Cells ,COVID-19 ,Acute Kidney Injury ,medicine.disease ,Acquired immune system ,Inflammaging ,Immunity, Innate ,medicine.anatomical_structure ,Immune System ,Hemodialysis ,Immunology ,business ,Kidney disease - Abstract
Elderly individuals with chronic disorders tend to develop inflammaging, a condition associated with elevated levels of blood inflammatory markers, and increased susceptibility to chronic disease progression. Native and adaptive immunity are both involved in immune system senescence, kidney fibrosis and aging. The innate immune system is characterized by a limited number of receptors, constantly challenged by self and non-self stimuli. Circulating and kidney resident myeloid and lymphoid cells are all equipped with pattern recognition receptors (PRRs). Recent reports on PRRs show kidney overexpression of toll-like receptors (TLRs) in inflammaging autoimmune renal diseases, vasculitis, acute kidney injury and kidney transplant rejection. TLR upregulation leads to proinflammatory cytokine induction, fibrosis, and chronic kidney disease progression. TLR2 blockade in a murine model of renal ischemia reperfusion injury prevented the escape of natural killer cells and neutrophils by inflammaging kidney injury. Tumor necrosis factor-α blockade in endothelial cells with senescence-associated secretory phenotype significantly reduced interleukin-6 release. These findings should encourage experimental and translational clinical trials aimed at modulating renal inflammaging by native immunity blockade.
- Published
- 2021
35. Evaluation of a novel advanced pharmacy technician role: discharge Medication Education Technician
- Author
-
Jenny Than, Margaret E Carroll, Brett J. Anderson, Ella EL-Katateny, Patrick Hilley, Simone E Taylor, Daniela Sepe, Andrea Verde, Jayne Droney, and Sally M. Mitchell
- Subjects
business.industry ,Technician ,Pharmacy ,medicine.disease ,Patient counselling ,Patient satisfaction ,Workforce ,Medicine ,media_common.cataloged_instance ,Pharmacology (medical) ,Pharmacy practice ,Medical emergency ,business ,Pharmacy technician ,media_common - Published
- 2021
36. Predicting length of fatigue cracks by means of machine learning algorithms in the small-data regime
- Author
-
Marzia Sepe, Antonino Graziano, Maciej Badora, Marcin Bielecki, and Tomasz Szolc
- Subjects
Small data ,Computer science ,business.industry ,02 engineering and technology ,021001 nanoscience & nanotechnology ,Machine learning ,computer.software_genre ,Industrial and Manufacturing Engineering ,020303 mechanical engineering & transports ,0203 mechanical engineering ,Artificial intelligence ,0210 nano-technology ,Safety, Risk, Reliability and Quality ,business ,Algorithm ,computer - Abstract
In this paper several statistical learning algorithms are used to predict the maximal length of fatigue cracks based on a sample composed of 31 observations. The small-data regime is still a problem for many professionals, especially in the areas where failures occur rarely. The analyzed object is a high-pressure Nozzle of a heavy-duty gas turbine. Operating parameters of the engines are used for the regression analysis. The following algorithms are used in this work: multiple linear and polynomial regression, random forest, kernel-based methods, AdaBoost and extreme gradient boosting and artificial neural networks. A substantial part of the paper provides advice on the effective selection of features. The paper explains how to process the dataset in order to reduce uncertainty; thus, simplifying the analysis of the results. The proposed loss and cost functions are custom and promote solutions accurately predicting the longest cracks. The obtained results confirm that some of the algorithms can accurately predict maximal lengths of the fatigue cracks, even if the sample is small.
- Published
- 2021
37. Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators
- Author
-
Pierangela Sepe, Daniele Santini, Giandomenico Roviello, Ugo De Giorgi, Giuseppe Procopio, Alessia Mennitto, Marco Stellato, Davide Bimbatti, Marco Maruzzo, Andrea Sbrana, Chiara Casadei, and Sandro Pignata
- Subjects
0301 basic medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,Renal cell carcinoma ,Immune-related adverse events ,Internal medicine ,medicine ,Clinical endpoint ,Humans ,Progression-free survival ,Adverse effect ,education ,Carcinoma, Renal Cell ,Retrospective Studies ,education.field_of_study ,business.industry ,Research ,Cancer ,General Medicine ,Immunotherapy ,medicine.disease ,Kidney Neoplasms ,030104 developmental biology ,Italy ,030220 oncology & carcinogenesis ,Pancreatitis ,Medicine ,business - Abstract
Background Severe immune-related Adverse Events (irAEs) develop in 10–27% of patients treated with Immune-Oncology (IO) [Powles (Lancet 391:748–757, 2018); Galsky (Lancet 395:1547–1557, 2020); Haanen (Ann Oncol 28:119–142, 2017)]. The aim of our study was to evaluate efficacy and clinical outcome of metastatic renal cell carcinoma (mRCC) patients who stopped Immune Checkpoint Inhibitors (ICIs) due to early Grade (G) 3-G4 irAEs. Methods We retrospectively collected data from 204 mRCC patients treated with ICIs in 6 Italian referral centers adhering to the Meet-Uro group, between February 2017 and January 2020. To properly weight the results, patients who did not report early G3–G4 toxicities have been included as control group. Primary endpoint was to evaluate 6 months Progression Free Survival (PFS) after early treatment interruption for Grade (G) 3–4 toxicities compared to the control group. Secondary endpoints were to evaluate Time to treatment failure (TTF) and overall survival (OS) in both groups. All statistical analyses were performed using SPSS software (version 19.00, SPSS, Chicago). Results 18/204 (8.8%) patients had early treatment interruption for serious (G3-G4) irAEs. Early was defined as interruption of IO after only one or two administrations. Immune related nephritis and pancreatitis were the most common irAE that lead to treatment interruption. 6/18 patients received IO-IO combination whereas 12/18 patients antiPD1. In the study group, 12/18 (66.6%) were free from progression at 6 months since IO interruption, TTF was 1.6 months (95% CI 1.6–2.1), mPFS was 7.4 months (95% CI 3.16–11.6) and mOS was 15.5 months (5.1–25.8). In the control group 111/184 (60.3%) patients were free from progression at 6 months, TTF was 4.6 months (95% CI 3.5–5.6), mPFS was 4.6 months (95% CI 3.5–5.6) and mOS was 19.6 months (95% CI 15.1–24.0). In the overall population, mPFS was 5.0 months (95% CI 4.0–5.9) and mOS was 19.6 months (95% CI 15.1–24.0). Conclusions ICIs seem to maintain efficacy even after early interruption due to severe irAE.
- Published
- 2021
38. The Fundamentals of Polyethylene
- Author
-
Sepe, Mike
- Subjects
Polyethylene ,Polymer industry ,Polymers ,Business ,Chemicals, plastics and rubber industries - Abstract
PE properties can be adjusted either by changing the molecular weight or by altering the density. While this increases the possible combinations of properties, it also requires that the specification [...]
- Published
- 2019
39. PART 4: Heat Deflection Temperature Vs. Dynamic Mechanical Analysis: The presentation of DMA data can sometimes frustrate users and discourage its adoption. Those unfamiliar with DMA should insist on receiving data relevant to the manner in which the part they are developing will be used
- Author
-
Sepe, Mike
- Subjects
Backup software ,Vendor relations ,Engineers ,Databases ,Business ,Chemicals, plastics and rubber industries - Abstract
Having frequently recommended that engineers designing new products access DMA data, it is discouraging when they come back somewhat bewildered about what they obtain from either a material supplier or [...]
- Published
- 2019
40. New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study
- Author
-
Irina Perdivara, Ben Niu, Kim F. Haselmann, St John Skilton, Anthony Leone, Gregory O. Staples, Carsten P. Sønksen, Helena Maria Barysz, Andrew Hanneman, Chun Shao, Rebecca Scott, Anders Lund, Carly Daniels, Michael Jahn, Da Ren, Nunzio Sepe, K. Ilker Sen, Zoran Sosic, David Ripley, Jing Zhen, Margo Wilson, Melissa Alvarez, John G Hoogerheide, Xinbi Li, Harini Kaluarachchi, Josh Woods, Wenqin Ni, Albrecht Gruhler, Keith A. Johnson, Arnd Brandenburg, Kristen Nields, Michelle Busch, Douglas D. Richardson, Yan Wang, Ahmet Cansizoglu, Xiaoxiao Li, Greg W Adams, Simon Letarte, Joe Shambaugh, Hua Yuan, Trina Mouchahoir, Tom Robinson, Xiaoshi Wang, Nancy S. Nightlinger, Alexander Julian Veach, Chris Chumsae, Eric Carlson, Dongdong Wang, Sean Shen, Jing Fang, Wei Wu, Stefano Gotta, Justin B. Sperry, Hirsh Nanda, X. Christopher Yu, Sibylle Heidelberger, Bhumit A. Patel, Jihong Wang, Sean McCarthy, Himakshi Patel, Thomas N. Krogh, Hunter Walker, Olga V. Friese, Daniela Tizabi, Yali Lu, Kristin Boggio, Ernest L. Maynard, Rich Rogers, Ying Zhou, Nick DeGraan-Weber, John E. Schiel, Weibin Chen, Jason C. Rouse, Li Tao, Thomas W. Powers, John Kim, Xu Guo, Bo Yan, Gabriella Leo, Ying Zhang, Oleg V. Borisov, Ying Qing Yu, Martha Stapels, Wael Yared, Yan-Hui Liu, Alan Heckert, Sarah Rogstad, Li Zang, Aaron Ammerman, Li Cao, Benjamin J. Place, Richard Ludwig, Anton V. Manuilov, Andrew Mahan, Andrew Dawdy, Yi Wang, Brian Schmidt, and Peiran Liu
- Subjects
business.industry ,Chemistry ,Process (engineering) ,media_common.quotation_subject ,010401 analytical chemistry ,010402 general chemistry ,01 natural sciences ,0104 chemical sciences ,Peak detection ,Structural Biology ,Process engineering ,business ,Function (engineering) ,Spectroscopy ,media_common - Abstract
The Multi-Attribute Method (MAM) Consortium was initially formed as a venue to harmonize best practices, share experiences, and generate innovative methodologies to facilitate widespread integration of the MAM platform, which is an emerging ultra-high-performance liquid chromatography-mass spectrometry application. Successful implementation of MAM as a purity-indicating assay requires new peak detection (NPD) of potential process- and/or product-related impurities. The NPD interlaboratory study described herein was carried out by the MAM Consortium to report on the industry-wide performance of NPD using predigested samples of the NISTmAb Reference Material 8671. Results from 28 participating laboratories show that the NPD parameters being utilized across the industry are representative of high-resolution MS performance capabilities. Certain elements of NPD, including common sources of variability in the number of new peaks detected, that are critical to the performance of the purity function of MAM were identified in this study and are reported here as a means to further refine the methodology and accelerate adoption into manufacturer-specific protein therapeutic product life cycles.
- Published
- 2021
41. Promoting Judicious Primary Care Referral of Patients with Chest Pain to Cardiology: A Quality Improvement Initiative
- Author
-
Kathleen M. Kadow, Deena Berkowitz, Christina Driskill, Lena Saleh, Lexi Crawford, Ariel Dubelman, Lena Baram, Kathy Prestidge, Ashraf S Harahsheh, James E. Bost, Edward Sepe, and Ellen K. Hamburger
- Subjects
Adult ,Chest Pain ,medicine.medical_specialty ,Quality management ,Adolescent ,Referral ,Cardiac pathology ,Cardiology ,Primary care ,Chest pain ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Ambulatory care ,030225 pediatrics ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Child ,Referral and Consultation ,Primary Health Care ,business.industry ,Health Policy ,Quality Improvement ,medicine.symptom ,business ,Pediatric cardiology - Abstract
Objective To decrease referrals to cardiology of patients ages 7 to 21 years with low-probability cardiac pathology who presented to primary care with chest pain by 50% within 24 months. Study Design A multidisciplinary team designed and implemented an initiative consisting of 1) a decision support tool (DST), 2) educational sessions, 3) routine feedback to improve use of referral criteria, and 4) patient family education. Four pediatric practices, comprising 34 pediatricians and 7 nurse practitioners, were included in this study. We tracked progress via statistical process control charts. Results A total of 421 patients ages 7 to 21 years presented with chest pain to their pediatrician. The utilization of the DST increased from baseline of 16% to 68%. Concurrently, the percentage of low-probability cardiology referrals in pediatric patients ages 7 to 21 years who presented with chest pain decreased from 17% to 5% after our interventions. At a median follow-up time of 0.9 years (interquartile range, 0.3–1.6 years), no patient had a life-threatening cardiac event. Conclusion Our health care improvement initiative to reduce low-probability cardiology referrals for children presenting to primary care practices with chest pain was feasible, effective, and safe.
- Published
- 2021
42. Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder
- Author
-
Jessica R. Gilbert, Frederick W. Carver, Allison C. Nugent, Carlos A. Zarate, Linnea Sepe-Forrest, Maura L. Furey, and Nancy B. Lundin
- Subjects
medicine.medical_specialty ,Emotions ,Audiology ,Stimulus (physiology) ,behavioral disciplines and activities ,Article ,Depressive Disorder, Treatment-Resistant ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Generalizability theory ,Ketamine ,Valence (psychology) ,Depressive Disorder, Major ,medicine.diagnostic_test ,business.industry ,Magnetoencephalography ,medicine.disease ,Antidepressive Agents ,030227 psychiatry ,Facial Expression ,Psychiatry and Mental health ,Clinical Psychology ,Electrophysiology ,Major depressive disorder ,Antidepressant ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Background The glutamatergic modulator ketamine rapidly reduces depressive symptoms in individuals with treatment-resistant major depressive disorder (MDD). However, ketamine's effects on emotional processing biases remain largely unknown, and understanding these processes may help elucidate ketamine's mechanism of action. Methods Magnetoencephalography (MEG) was used to investigate ketamine's effects on early visual responses to affective stimuli in individuals with MDD (n=31) and healthy volunteers (HVs; n=24). Participants were enrolled in a double-blind, placebo-controlled, crossover clinical trial and were assessed at baseline and after subanesthetic-dose ketamine and placebo-saline infusions. During MEG recording, participants completed an emotional evaluation task in which they indicated the sex or emotional valence (happy-neutral or sad-angry) of facial stimuli. Source-localized event-related field (ERF) M100 and M170 amplitudes and latencies were extracted from regions of interest. Linear fixed effects models examined interactions between diagnosis, stimulus valence, and drug session for behavioral and MEG data. Results In baseline behavioral analyses, MDD participants exhibited higher accuracy for sad-angry than happy-neutral faces, and HVs responded faster to happy-neutral than sad-angry faces. In the MEG post-infusion analyses, calcarine M100 amplitudes were larger in MDD than HV participants post-placebo but became more similar post-ketamine. Finally, fusiform M170 amplitudes were associated with antidepressant response in MDD participants. Limitations The modest sample size and the need to collapse across responses to happy and neutral faces to increase statistical power limit the generalizability of the findings. Conclusions Ketamine rapidly altered emotional stimulus processing in MDD, laying the groundwork for future investigations of biomarkers of antidepressant treatment response. Clinical Trial Clinicaltrials.gov, NCT#00088699
- Published
- 2021
43. Cloud Segmentation of Sentinel-2 Images Using Convolutional Neural Network with Domain Adaptation
- Author
-
Giovanni Poggi, Pasquale Sepe, Giuseppe Scarpa, Antonio Mazza, Mazza, Antonio, Sepe, Pasquale, Poggi, Giovanni, and Scarpa, Giuseppe
- Subjects
Computer science ,business.industry ,Multispectral image ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,Weather forecasting ,Pattern recognition ,Cloud computing ,Image segmentation ,computer.software_genre ,Convolutional neural network ,Face (geometry) ,Segmentation ,Artificial intelligence ,business ,Raw data ,computer - Abstract
Cloud segmentation of remotely sensed multispectral images is an important topic not only for weather forecast but, more in general, for establishing when the sensed data actually relate to the soil so that can be reliably used for some monitoring purpose. In this work, leveraging on the capability of convolutional neural networks to accurately approximate complex relationships between raw data and higher-level products, we propose a U-Net-like solution conceived for Sentinel-2 images. In order to face the scarsity of training data, a proper domain adaptation strategy has been pursued, which resorts to a labeled Landsat-8 dataset. Preliminary results show a consistent improvement over standard tools.
- Published
- 2021
44. FEM Simulation and Experimental Tests on the SMAW Welding of a Dissimilar T-Joint
- Author
-
Venanzio Giannella, Alessandro De Luca, Alessandro Greco, R. Sepe, Sepe, R., Giannella, V., Greco, A., and De Luca, A.
- Subjects
0209 industrial biotechnology ,Materials science ,Element birth and death ,Shielded metal arc welding ,02 engineering and technology ,Welding ,law.invention ,Residual stresses ,020901 industrial engineering & automation ,0203 mechanical engineering ,law ,Thermocouple ,Residual stress ,Distortion ,General Materials Science ,T-joint ,Image warping ,Mining engineering. Metallurgy ,Finite element method (FEM) ,Dissimilar materials ,Distortions ,Shielded metal arc welding (SMAW) ,Simulation ,T‐joint ,business.industry ,Dissimilar material ,Metals and Alloys ,TN1-997 ,Residual stresse ,Structural engineering ,Finite element method ,020303 mechanical engineering & transports ,shielded metal arc welding (SMAW) ,element birth and death ,distortions ,residual stresses ,finite element method (FEM) ,dissimilar materials ,simulation ,Fe model ,business - Abstract
Residual stresses induced by the welding processes may, in some cases, result in significant warping and distortions that can endanger the integrity of the welded structures. This document reports an investigation of the welding process to make a dissimilar T-joint through an advanced Finite Element (FE) modelling and a dedicated laboratory test. The T-joint consisted of two plates of dissimilar materials, AISI304 and S275JR steels, both having a thickness of 5 mm, welded through a Shielded Metal Arc Welding (SMAW). Thermocouples were used to acquire the temperature variations during welding. In parallel, an FE model was built and the welding process was simulated through the “element birth and death” technique. Numerical and experimental outcomes were compared in terms of temperature distributions during welding and in terms of distortion at the end of the final cooling, showing that the FE model was able to provide a high level of accuracy.
- Published
- 2021
- Full Text
- View/download PDF
45. Numerical Investigation on the Influence of Tightening in Bolted Joints
- Author
-
Giuseppe Lamanna, Alessandro Greco, A. De Luca, Raffaele Sepe, F. Furgiuele, N. Bonora, L. Bruno, F. Cianetti, G. Meneghetti, G. Mirone, M. Sasso, F. Iacoviello, Greco, A., De Luca, A., Lamanna, G., and Sepe, R.
- Subjects
Tightening torque ,Materials science ,business.industry ,digestive, oral, and skin physiology ,Bolted joints ,Numerical modeling ,02 engineering and technology ,Structural engineering ,021001 nanoscience & nanotechnology ,Finite element method ,Stress (mechanics) ,Preload ,020303 mechanical engineering & transports ,Lap joint ,0203 mechanical engineering ,Bolted joint ,Ultimate tensile strength ,0210 nano-technology ,business ,Joint (geology) ,Strain gauge ,Earth-Surface Processes - Abstract
In a bolted joint, the preload level resulting from the tightening torque represents a very important parameter governing the stresses distributions involving the joint under the real loading conditions. This paper deals with the development of a Finite Element (FE) model for the investigation of the effects of some selected preload levels on the stress-strain states affecting both bolt and plate in a single lap joint. The aim of this FE model is to support the design phase of strain gauges instrumented bolt to evaluate experimentally the rate of tensile load applied to the joint that the bolt absorbs with different preloads. The test article consists of two steel plates, a steel bolt and an aluminum nut. The results herein presented showed firstly that, without bolt preload, the tensile load applied to the joint is completely transferred to the bolt and that the load transferred to the bolt almost linearly decreases as the preload increases. Moreover, at a selected preload level, the transversal and longitudinal stresses (with respect to the load direction) increase as the tensile load increases, while the stress along the plate thickness direction decreases, reaching negative values. On the other hand, at a selected tensile load level, the transversal and longitudinal stresses as well as the stress along the thickness direction decrease as the preload level increases. Predicting the mechanical behaviour of the only bolted joint, if the same bolt model will be used to simulate the mechanical behaviour in a hybrid single-lap joint, possible imperfections of the model will have to certainly be linked to the modelling of the adhesive.
- Published
- 2019
46. Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma
- Author
-
Alessia Mennitto, Pierangela Sepe, Francesca Corti, and Giuseppe Procopio
- Subjects
Oncology ,medicine.medical_specialty ,Cabozantinib ,Mechanism (biology) ,business.industry ,Angiogenesis ,medicine.medical_treatment ,Standard treatment ,Immunology ,Immunotherapy ,urologic and male genital diseases ,medicine.disease ,Targeted therapy ,Unmet needs ,chemistry.chemical_compound ,chemistry ,Renal cell carcinoma ,Internal medicine ,medicine ,Immunology and Allergy ,business - Abstract
Over the last 20 years, different therapies have been considered as the mainstay for the treatment of patients with metastatic renal cell carcinoma (mRCC). Since angiogenesis is a key mechanism in the pathogenesis of renal carcinoma, research is still focusing on the inhibition of new vessel growth through the development of novel and potent tyrosine kinase inhibitors (TKIs), such as cabozantinib. On the other hand, a new therapeutic scenario has opened up in the forefront with immunotherapy. Immune checkpoint inhibitors (ICIs), which already represent a standard treatment option in pretreated mRCC patients, are revolutionizing the frontline therapeutic armamentarium of mRCC. Upfront combination immunotherapy as well as combinations of immunotherapy with targeted agents showed to significantly improved outcomes of mRCC patients compared to single-agent TKIs. ICIs are associated with long-lasting responses. Nonetheless, several unmet needs remain, as a small proportion of patients shows primary refractoriness to immunotherapy. Multiple treatment strategies combining different mechanisms of action or targeting immune escape pathways are emerging with the aim to improve response rates and survival outcomes. This review summarizes current immunotherapeutic targets and therapies approved for mRCC, while examining mechanisms of resistance and future directions, with the aim to address novel treatment strategies and help in improving the management of this tumor.
- Published
- 2020
47. Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia
- Author
-
Maria Antonietta Grignano, Raffaele Bruno, Riccardo Albertini, Mauro Valente, Vincenzo Sepe, Carmelo Libetta, Fiorenza Ferrari, Mirko Belliato, Tefik Islam, Teresa Rampino, Luciano Perotti, Eleonora Francesca Pattonieri, Marilena Gregorini, and Alberto Garrone
- Subjects
Male ,ARDS ,Polymers ,medicine.medical_treatment ,030232 urology & nephrology ,Case Report ,030204 cardiovascular system & hematology ,Blood purification ,law.invention ,0302 clinical medicine ,Randomized controlled trial ,Critical illness cytokines ,law ,Adrenal Cortex Hormones ,Respiratory function ,Continuous positive airway pressure ,Continuous Positive Airway Pressure ,Hematology ,General Medicine ,Middle Aged ,Hemoperfusion ,Intensive care unit ,Combined Modality Therapy ,Intensive Care Units ,Nephrology ,Cytokines ,Drug Therapy, Combination ,Female ,Cytokine Release Syndrome ,Hydroxychloroquine ,medicine.medical_specialty ,Vinyl Compounds ,Critical Care ,Critical Illness ,Antibodies, Monoclonal, Humanized ,Antiviral Agents ,03 medical and health sciences ,Internal medicine ,medicine ,Adjuvant therapy ,Intubation, Intratracheal ,Humans ,Lymphocyte Count ,business.industry ,SARS-CoV-2 ,COVID-19 ,medicine.disease ,COVID-19 Drug Treatment ,Pneumonia ,Polystyrenes ,business ,Procedures and Techniques Utilization - Abstract
We report a preliminary experience of adjuvant therapy with Hemoperfusion (HP) in patients with Severe Acute Respiratory Syndrome-CoronaVirus 2 (SARS-CoV2) pneumonia. Currently, there are no approved treatments for CoronaVirus Disease 19 (COVID-19); however, therapeutic strategies based on the preclinical evidence include supportive measures, such as oxygen supplementation, antiviral, and anticoagulant agents. Despite these treatments, 10% of patients worsen and develop severe acute respiratory distress syndrome (ARDS). Since the pathogenic mechanism of ARDS is an uncontrolled inflammatory state, we speculate that removing inflammation effectors from blood may contrast tissue injury and improve clinical outcome. In a scenario of dramatic medical emergency, we conducted an observational study on 9 consecutive patients hospitalized in COVID Intensive Care Unit, where 5 of 9 consecutive patients were treated with HP, due to the emergency overload made it impossible to deliver blood purification in the other 4 patients. COVID-19 was diagnosed through the identification of virus sequences by reverse transcription-PCR on respiratory specimens. All patients had severe pneumonia requiring continuous positive airway pressure. HP was started in all patients 6–7 days after hospital admission. The treated patients (T) received 2 consecutive sessions of HP using CytoSorb cartridge. Our results show a better clinical course of T compared to control patients (C), in fact all T except 1 survived, and only 2 of them were intubated, while all C required intubation and died. Lymphocytopenia worsened in C but not in T. C-reactive protein decreased in both patients, but to a greater extent in T. IL-6, IL-8, and TNF-α decreased after HP, IL-10 did not change. Respiratory function remained stable and did not worsen in T compared to C. The limited sample size and observational study design preclude a sound statement about the potential effectiveness of HP in COVID-19 patients, but our experience suggests a potential therapeutic role of adjuvant CytoSorb HP in the early course of COVID-19 pneumonia. A randomized clinical trial is ongoing.
- Published
- 2020
48. Industrial gas turbine operating parameters monitoring and data-driven prediction
- Author
-
Marzia Sepe, Maciej Badora, Alessandro De Luca, Szymon Fulara, and Maciej Pawełczyk
- Subjects
business.industry ,Environmental science ,Industrial gas ,Safety, Risk, Reliability and Quality ,Process engineering ,business ,Turbine ,Industrial and Manufacturing Engineering ,Data-driven - Abstract
The article reviews traditional and modern methods for prediction of gas turbine operating characteristics and its potential failures. Moreover, a comparison of Machine Learning based prediction models, including Artificial Neural Networks (ANN), is presented. The research focuses on High Pressure Compressor (HPC) recoup pressure level of 4th generation LM2500 gas generator (LM2500+G4) coupled with a 2-stage High Speed Power Turbine Module. The researched parameter is adjustable and may be used to balance net axial loads exerted on thrust bearing to ensure stable gas turbine operation, but its direct measurement is technically difficult implicating the need to indirect measurement via set of other gas turbine sensors. Input data for the research have been obtained from BHGE manufactured and monitored gas turbines and consists of real-time data extracted from industrial installations. Machine learning models trained using the data show less than 1% Mean Absolute Percentage Error (MAPE) as obtained with the use of Random Forest and Gradient Boosting Regression models. Multilayer Perceptron Artificial Neural Networks (MLP ANN) models are reviewed, and their performance checks inferior to Random Forest algorithm-based model. The importance of hyperparameter tuning and feature engineering is discussed.
- Published
- 2020
49. The emerging role of PARP inhibitors in prostate cancer
- Author
-
Alessia Mennitto, Giuseppe Procopio, Pierangela Sepe, Giuseppe Tonini, Melanie Claps, Marco Stellato, Elena Verzoni, Emma Zattarin, Riccardo Valdagni, Daniele Santini, Filippo de Braud, and Valentina Guadalupi
- Subjects
Male ,0301 basic medicine ,DNA Repair ,Veliparib ,Poly ADP ribose polymerase ,Antineoplastic Agents ,Poly(ADP-ribose) Polymerase Inhibitors ,Olaparib ,03 medical and health sciences ,chemistry.chemical_compound ,Prostate cancer ,0302 clinical medicine ,Drug Development ,Animals ,Humans ,Medicine ,Talazoparib ,Pharmacology (medical) ,Rucaparib ,Gene ,business.industry ,medicine.disease ,Prostatic Neoplasms, Castration-Resistant ,030104 developmental biology ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,Mutation ,Cancer research ,business ,Homologous recombination ,human activities - Abstract
In prostate cancer , there has recently been an emerging interest in mutations in genes belonging to the homologous recombination repair (HRR) pathway and in the inhibition of poly (ADP-ribose) polymerase (PARP) proteins.Mutations in the HRR genes, including BRCA1, BRCA2, and Ataxia-Telangiesctasia mutated (ATM), have been reported in prostate cancer, with different incidence in the localized and advanced settings. The PARP enzyme complex is involved in repair of DNA damage and its inhibition causes the accumulation of DNA mutations in HRR deficient cells. Several PARP inhibitors (PARPi) are under development, such as olaparib, talazoparib, niraparib, rucaparib, and veliparib. In metastatic castration resistant prostate cancer (mCRPC), olaparib has been the most studied and its clinical efficacy has been validated in a phase III clinical trial. Rucaparib and niraparib have also shown promising results in the preliminary analyzes of two phase II trials, while talazoparib is currently under development.PARPi have become part of the treatment of mCRPC. Early results of combination therapy with PARPi and new hormonal therapy are promising and are supported by a strong biological rationale. Current results need to be validated in randomized phase III-controlled trials in order to translate the use of PARPi into real world practice.
- Published
- 2020
50. Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study)
- Author
-
Massimo Di Maio, Marco Stellato, Alessia Mennitto, Elena Verzoni, Paolo Grassi, Valentina Guadalupi, Elisa Sottotetti, Alessandra Raimondi, Giuseppe Procopio, Melanie Claps, Pierangela Sepe, Emma Zattarin, and Antonia Martinetti
- Subjects
Male ,Vascular Endothelial Growth Factor A ,Oncology ,Cancer Research ,circulating angiogenic factors ,Drug Resistance ,Angiogenesis Inhibitors ,Translational Research, Biomedical ,0302 clinical medicine ,Renal cell carcinoma ,pazopanib ,Prospective Studies ,030212 general & internal medicine ,Osteopontin ,Prospective cohort study ,Translational Medical Research ,Sulfonamides ,biology ,Hepatocyte Growth Factor ,circulating biomarkers ,Middle Aged ,TKI ,Kidney Neoplasms ,Progression-Free Survival ,Survival Rate ,Response Evaluation Criteria in Solid Tumors ,030220 oncology & carcinogenesis ,Disease Progression ,Female ,E-Selectin ,medicine.drug ,renal cell carcinoma ,medicine.medical_specialty ,Indazoles ,Antineoplastic Agents ,Aged ,Carcinoma, Renal Cell ,Chemokine CXCL12 ,Humans ,Interleukin-6 ,Interleukin-8 ,Pyrimidines ,Drug Resistance, Neoplasm ,Pazopanib ,03 medical and health sciences ,Internal medicine ,Carcinoma ,medicine ,Progression-free survival ,Survival rate ,business.industry ,Renal Cell ,medicine.disease ,biology.protein ,Neoplasm ,business - Abstract
Objectives Despite the initial clinical benefit, resistance to antiangiogenic therapies develops through the activation of alternative pathways. We measured plasma levels of circulating angiogenic factors to explore their predictive role in metastatic renal cell carcinoma (mRCC) patients treated with pazopanib. Materials and methods mRCC patients receiving first-line pazopanib were prospectively enrolled. The levels of circulating interleuchine (IL)-6, IL-8, stromal derived factor-1, vascular endothelial growth factor-A, hepatocyte growth factor (HGF), osteopontin, and E-selectin were quantified at baseline and every 4 weeks until disease progression (PD). Patients were dichotomized into "low" and "high" subgroups by a cutoff point defined by the respective median circulating angiogenic factor (CAF) value at baseline. Then, association with the objective response was determined. Changes in CAF levels between baseline and PD were also compared. Results Among 25 patients included in the final data set, 6 patients were still on treatment. As best response, 12 patients presented a partial response (48%), 9 showed stable disease, and 4 showed PD. The median follow-up was 31.9 months. The median progression-free survival was 14.8 months. Low baseline levels of IL-6, IL-8, HGF, and osteopontin were found to be significantly associated with objective response. In addition, patients with low baseline levels of HGF showed longer progression-free survival and overall survival, whereas patients with low baseline levels of IL-8 showed longer overall survival. Among patients experiencing PD, the median plasma levels of stromal derived factor-1 and vascular endothelial growth factor-A were significantly higher compared with the baseline (P=0.01; P=0.011). Conversely, the median levels of E-selectin were significantly lower compared with the baseline (P=0.017). Conclusion Changes in levels of selected CAFs were associated with response/resistance to pazopanib in mRCC patients.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.